Update Your ProfileAcademic Title:
Faculty Member
Primary Appointment:
Medicine
Administrative Title:
Executive Director, University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC); Chief of Service, University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC); Associate Vice President, Cancer Programs; Senior Associate Dean, UMB Cancer Programs; Executive Director, UMSOM Program in Oncology
Location:
SOM Oncology Program, North Hospital UMMC, Rm. N9E22
Phone (Primary):
410-328-5506
Education and Training
- Obafemi Awolowo University, Nigeria, MD/PhD, 1991
- Obafemi Awolowo University, Nigeria, Internship, 1992
- Pennsylvania Hospital, Philadelphia, PA, Residency, 2005
- Lagos University Teaching Hospital, Nigeria, Residency, 1998
- Heinrich Heine University Medical School, Düsseldorf, Germany, Residency, 2002
- UPMC Presbyterian, Pittsburgh, PA, Fellowship, Hematology/Oncology, 2008
- Johns Hopkins University, Baltimore, MD, Research Fellowship - Imaging, 2002
Certification:
American Board of Internal Medicine - Medical Oncology, 2018
Biosketch
Dr. Owonikoko is a thoracic medical oncologist who specializes in treating patients with lung cancer. His clinical interests include medical oncology (diagnosis and treatment of cancer), hematology (diagnosis and treatment of blood disorders) and internal medicine (treatment of diseases in adults).
He is the executive director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, a National Cancer Institute-Designated Cancer Center. He is also the senior associate dean of cancer programs at University of Maryland School of Medicine. In addition, he is the associate vice president of cancer programs at University of Maryland, Baltimore.
Dr. Owonikoko is a distinguished translational physician-scientist. His research interests include preclinical experimental therapeutics, biomarker discovery and translation of promising laboratory findings into clinical trials. He has received peer-reviewed extramural grant funding for his research from the US National Institutes of Health, the Department of Defense, private foundations and pharmaceutical partners.
Dr. Owonikoko is as an elected board member and treasurer-elect of the American Society of Clinical Oncology. He is also an editorial board member for several highly regarded academic journals, including Cancer, Frontiers in Oncology, Journal of Thoracic Disease and Translational Lung Cancer Research. In addition, he is a member of the American College of Physicians, American Society for Hematology, Society for Immunotherapy of Cancer and International Association for the Study of Lung Cancer. He has been a National Institutes of Health Study Section member for over a decade.
Research/Clinical Keywords
preclinical experimental therapeutics, biomarker discovery and translation of promising laboratory findings into clinical trials
Research Interests
Preclinical experimental therapeutics, biomarker discovery and translation of promising laboratory findings into clinical trials.